• Bloomberg


The European Union is poised to tighten rules on the export of COVID-19 vaccines, risking a major escalation in the global battle to secure access to the life-saving shots.

With EU governments under fire over the shortfall in deliveries from drugmakers including AstraZeneca Plc, the EU’s executive arm will on Friday require companies seeking to ship the inoculations outside the bloc to obtain prior authorization.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.